Average Co-Inventor Count = 3.97
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Array Biopharma Inc. (15 from 329 patents)
2. University of Colorado (7 from 1,379 patents)
3. American Home Products Corporation (3 from 1,567 patents)
4. Wyeth (3 from 1,309 patents)
5. Suvica, Inc. (2 from 2 patents)
6. Onkure, Inc. (1 from 7 patents)
29 patents:
1. 11339150 - Benzimidazole compounds as HDAC6 inhibitors
2. 11267818 - Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds
3. 10774085 - Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compounds
4. 10590139 - Method of treatment using substituted imidazo[1,2b]pyridazine compounds
5. 10508122 - Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof
6. RE47690 - Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof
7. 10259846 - Bouvardin derivatives and therapeutic uses thereof
8. 10047097 - Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds
9. 10011604 - Method of treatment using substituted imidazo[1,2b]pyridazine compounds
10. 10005783 - Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds
11. 9840520 - Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof
12. 9795611 - Method of treatment using substituted imidazo[1,2b]pyridazine compounds
13. 9796723 - Method of treatment using substituted imidazo[1,2b]pyridazine compounds
14. 9676783 - Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compounds
15. 9452215 - Bourvadin derivatives and therapeutic uses thereof